Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Klinisk Tandtekniker Ninna Aarøe Nielsen ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   10.9% 20.6% 10.9% 9.7% 8.2% 12.3% 13.1% 12.7%   Credit score (0-100)   23 5 21 24 29 19 18 18   Credit rating   BB B BB BB BB BB BB BB   Credit limit (kDKK)   0.0 -0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   1,349 847 1,200 0 0 0 0 0   Gross profit   864 519 829 829 895 762 0.0 0.0   EBITDA   99.9 -98.9 209 205 204 46.3 0.0 0.0   EBIT   30.5 -158 150 146 155 9.4 0.0 0.0   Pre-tax profit (PTP)   30.5 -172.1 138.9 134.9 145.5 5.8 0.0 0.0   Net earnings   22.7 -171.7 140.4 109.1 114.3 3.5 0.0 0.0   Pre-tax profit without non-rec. items   30.5 -172 139 135 146 5.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   85.1 61.4 37.6 13.9 0.0 23.1 0.0 0.0   Shareholders equity total   72.7 -99.1 41.3 150 165 68.3 18.3 18.3   Interest-bearing liabilities   325 266 204 140 76.3 1.4 17.4 17.4   Balance sheet total (assets)   450 313 369 416 379 180 35.7 35.7   Net Debt   202 208 33.6 -138 -221 -109 17.4 17.4     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   1,349 847 1,200 0 0 0 0 0   Net sales growth   0.0% -37.2% 41.7% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   864 519 829 829 895 762 0.0 0.0   Gross profit growth   0.0% -39.9% 59.6% 0.1% 7.9% -14.9% -100.0% 0.0%   Employees   0 0 0 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   -763.6 -618.0 -619.4 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   450 313 369 416 379 180 36 36   Balance sheet change%   0.0% -30.6% 18.0% 12.8% -8.8% -52.6% -80.1% 0.0%   Added value   863.5 519.1 828.7 205.1 214.4 46.3 0.0 0.0   Added value %   64.0% 61.3% 69.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   230 -119 -119 -119 -99 -50 -23 0   Net sales trend   0.0 -1.0 1.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   7.4% -11.7% 17.4% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   2.3% -18.7% 12.5% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.5% -30.5% 18.1% 17.6% 17.3% 1.2% 0.0% 0.0%   Net Earnings %   1.7% -20.3% 11.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   6.8% -13.3% 16.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   2.3% -20.3% 11.6% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.8% -36.7% 38.4% 37.1% 39.0% 3.4% 0.0% 0.0%   ROI %   7.7% -47.7% 58.6% 54.3% 58.2% 6.0% 0.0% 0.0%   ROE %   31.2% -89.1% 79.3% 113.8% 72.5% 3.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   16.1% -24.1% 11.2% 36.2% 43.5% 38.0% 51.2% 51.2%   Relative indebtedness %   28.0% 48.6% 27.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   18.9% 41.7% 13.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   202.7% -210.0% 16.0% -67.5% -108.0% -234.4% 0.0% 0.0%   Gearing %   446.9% -268.5% 494.5% 93.4% 46.3% 2.0% 95.4% 95.4%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.6% 4.7% 6.2% 8.7% 9.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   3.2 0.4 1.4 1.1 1.4 1.0 0.0 0.0   Current Ratio   3.4 0.5 1.5 1.1 1.4 1.1 0.0 0.0   Cash and cash equivalent   122.3 58.2 170.9 279.0 297.0 110.0 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 6.3 1.9 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   11.2% 8.6% 15.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   106.8 -73.0 65.3 29.5 93.4 10.5 -8.7 -8.7   Net working capital %   7.9% -8.6% 5.4% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 205 214 46 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 205 204 46 0 0   EBIT / employee   0 0 0 146 155 9 0 0   Net earnings / employee   0 0 0 109 114 3 0 0